Adarsh Joshi

Safety, efficacy and pharmacodynamics of vesatolimod (GS-9620) in virally suppressed patients with chronic hepatitis B

Harry L.A. Janssen, Maurizia Rossana Brunetto, Yoon Jun Kim et al. · Journal of Hepatology · 2017 · 201 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +12

A Phase II and Biomarker Study of Ramucirumab, a Human Monoclonal Antibody Targeting the VEGF Receptor-2, as First-Line Monotherapy in Patients with Advanced Hepatocellular Cancer

Andrew X. Zhu, Richard S. Finn, Mary F. Mulcahy et al. · Clinical Cancer Research · 2013 · 165 citations · Full text

Medicine, Oncology, Pharmacology +17

Phase 2 study of idelalisib and entospletinib: pneumonitis limits combination therapy in relapsed refractory CLL and NHL

Paul M. Barr, Gene Saylors, Stephen E. Spurgeon et al. · Blood · 2016 · 142 citations

Medicine, Pharmacology, Pharmacotherapy +7

Combined GS-4774 and Tenofovir Therapy Can Improve HBV-Specific T-Cell Responses in Patients With Chronic Hepatitis

Carolina Boni, Harry L.A. Janssen, Marzia Rossi et al. · Gastroenterology · 2019 · 140 citations · Full text

Pharmacy, Immunology, Infectious Diseases +13

Congestive jejunopathy in portal hypertension.

Aabha Nagral, Adarsh Joshi, Shobna Bhatia et al. · Gut · 1993 · 86 citations · Full text

Medicine, Internal Medicine, Pathology +11